Investor Presentaiton
Impact of COVID-19
Our work with COVID-19
Our strategy to combat COVID-19
(山店或權失投武汉,十分夺秒运送物资
WEGO威高
威高集团于部职工
为新冠味味喻防控工作
捐款1000821万元
000
BT TE mm
WOO
Since the outbreak of COVID-19 as early as December 2019, the
pandemic has caused an unprecedented impact to both global health and
the global economy.
To pledge our support to the frontline workers, the Weigao Group,
including our employees, have collectively donated RMB50 million in
medical products and funds throughout our fight against COVID-19:
On January 28, Weigao was among the first batch of companies to
donate medical supplies to Huoshenshan Hospital. In total, Weigao
donated more than RMB3 million of supplies to Huoshenshan Hospital,
and continued to organize the company-wide donation of various
supplies' to the country's efforts against COVID-19;
By the end of February, Weigao's staff collectively donated a total of
RMB20.4 million to our country's efforts against COVID-19;
By mid-March, we had donated surgical gowns, isolation gowns,
protective suits, masks, disinfectants, infusion equipment, blood
collection devices, blood transfusion sets, IV catheters, medical
equipment and other medical supplies worth more than RMB30 million.
WEGO威高
Despite the extended impact of COVID-19, our diversification strategy, in
terms of both product mix and geographic markets, has shown strong
results in mitigating risk throughout 1H2020.
Safeguarding the health of our employees and to our customers continues
to be a crucial goal for us. While the pandemic has largely stabilized in
China, we will continue to ensure we have the right protocols in place to
protect the health of our workers and ensure that our product supply to our
customers remain uninterrupted in the event of a resurgence.
As the COVID-19 situation continues to stabilize, we intend to continue our
stated strategy of product upgrades, import substitution, investments in
technology and resource sharing to ensure that our business continues to
grow in the coming years.
Our management believes that through our diversified businesses and
high quality products, we are able to continue consolidating our market
leading position in China. At the same time, we will continue to promote
opportunities to achieve synergies across our global platform, with a view
to support our corporate growth both domestically and abroad.
2View entire presentation